Baseline clinical characteristics, ECG and echocardiography in complete cohort (n=140)
| Baseline clinical characteristics | |
| Age | 83±7 |
| Blood pressure, diastolic, mm Hg | 73±11 |
| Blood pressure, systolic, mm Hg | 140±24 |
| Body surface area, m² | 1.8±0.2 |
| Body mass index, kg/m2 | 24.6±4.3 |
| CAD history, n (%) | 73 (52) |
| Logistic EuroSCORE | 16.2±10.2 |
| Male/female, n (% female) | 72/68 (49) |
| NYHA class | 2.5±0.6 |
| ECG | |
| Sinus rhythm, n (%) | 108 (77) |
| Atrial fibrillation, n (%) | 32 (23) |
| QRS duration <120 ms, n (%) | 113 (81) |
| Pre-existing conduction abnormalities, n (%) | 27 (19) |
| LBBB, n | 10 |
| RBBB, n | 9 |
| Unspecific conduction abnormalities, n | 8 |
| Echocardiography | |
| Aortic valve area, cm2 | 0.7±0.2 |
| Aortic valve mean pressure gradient, mm Hg | 54±18 |
| Aortic valve peak velocity, m/s | 4.5±0.7 |
| E/e′ | 21±11 |
| LA volume, mL/m2 | 57±18 |
| LV end-diastolic diameter, mm | 50±8 |
| LV ejection fraction, % | 52±11 |
| LV mass (men), g/cm2 | 111±24 |
| LV mass (women), g/cm2 | 102±22 |
| Stroke volume index, mL/m2 | 40±10 |
| Tricuspid annular plane systolic excursion, mm | 21±6 |
| Tricuspid regurgitation gradient, mm Hg | 36±13 |
Values are mean±SD deviation unless otherwise indicated.
CAD, coronary artery disease; e′, early diastolic mitral annular tissue velocity; E, early diastolic mitral inflow velocity; LA, left atrial; LBBB, left bundle branch block; LV, left ventricular; NYHA, New York Heart Association; RBBB, right bundle branch block.